Similar Search Results

Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy

Krulichova, Iva; Gamba, Sara; Ricci, Elena; Garattini, Livio - In: The European Journal of Health Economics 5 (2004) 4, pp. 330-334

Persistent link: https://www.econbiz.de/10009404255

Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices

Curto, Sandro; Ghislandi, Simone; van de Vooren, Katelijne - In: Health Policy 116 (2014) 2, pp. 182-187

The goal of the present study is to assess the awarded prices and thus the real level of competition the regional tenders referring to biosimilars in Italy achieved.

Persistent link: https://www.econbiz.de/10010776768

Should we really worry about “launch delays” of new drugs in OECD countries?

Garattini, Livio; Ghislandi, Simone - In: The European Journal of Health Economics 8 (2007) 1, pp. 1-3

Persistent link: https://www.econbiz.de/10005391156

Off-patent drugs in Italy

Garattini, Livio; Ghislandi, Simone - In: The European Journal of Health Economics 7 (2006) 1, pp. 79-83

Persistent link: https://www.econbiz.de/10005391169

A Simple Measure of Human Development : The Human Life Indicator

Ghislandi, Simone; Sanderson, Warren C.; Scherbov, Sergei - In: Population and Development Review 45 (2018) 1, pp. 219-233

Persistent link: https://www.econbiz.de/10012095767

Adaptation to poverty in long-run panel data

Clark, Andrew E.; D'Ambrosio, Conchita; Ghislandi, Simone - In: The review of economics and statistics 98 (2016) 3, pp. 591-600

Persistent link: https://www.econbiz.de/10011555801

Investigating the geographic disparity in quality of care : the case of hospital readmission after acute myocardial infarction in Italy

Wang, Yuxi; Ghislandi, Simone; Torbica, Aleksandra - In: The European journal of health economics : HEPAC ; … 21 (2020) 8, pp. 1149-1168

Persistent link: https://www.econbiz.de/10012490496

The impact of generic reference pricing in Italy, a decade on

Ghislandi, Simone; Armeni, Patrizio; Jommi, Claudio - In: The European Journal of Health Economics 14 (2013) 6, pp. 959-969

We provide the first empirical results of the impact of GRP on prices in Italy and evidence that GRP cannot be held solely responsible for the often reported demand reallocation towards new and in-patent molecules. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013

Persistent link: https://www.econbiz.de/10010993851

Effects of Reference Pricing in Pharmaceutical Markets

Galizzi, Matteo; Ghislandi, Simone; Miraldo, Marisa - In: PharmacoEconomics 29 (2011) 1, pp. 17-33

This work aims to provide a systematic and updated survey of original scientific studies on the effect of the introduction of reference pricing (RP) policies in Organisation for Economic Co-operation and Development (OECD) countries. We searched PubMed, EconLit and Web of Knowledge for articles...

Persistent link: https://www.econbiz.de/10010849011

Effects of Reference Pricing in Pharmaceutical Markets: A Review

Galizzi, Matteo Maria.; Ghislandi, Simone; Miraldo, Marisa - In: PharmacoEconomics 29 (2011) 1, pp. 17-33

Persistent link: https://www.econbiz.de/10010614402